EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EA Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10613
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies for the treatment of gastrointestinal and metabolic diseases. Its pipeline products are used for ulcerative colitis, osteoporosis and chronic constipation diseases. EA Pharma provides drug discovery, production and logistics, sales and marketing, and research and development services. The organization serves various sectors such as medical and healthcare. It markets its products through its network of distributors. EA Pharma is headquartered in Tokyo, Japan.

EA Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
EA Pharma Enters into Collaboration Agreement with Keio University, Tokyo Medical and Dental University, Kitasato University, Nagoya City University, Kagoshima University and KAN Research Institute 11
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 13
EA Pharma Enters into Co-Promotion Agreement with AbbVie 14
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 15
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
Licensing Agreements 18
Tasly Pharma Enters into Licensing Agreement with EA Pharma 18
EA Pharma to Enter into Licensing Agreement with Cosmo Technologies 19
JW Pharma Enters into Licensing Agreement with EA Pharma 20
EA Pharma Enters into Licensing Agreement with Calypso Biotech 21
LTT Bio-Pharma Enters into License Agreement with Ajinomoto Pharma 22
Ajinomoto Pharma Amends Licensing Agreement with Albireo for Elobixibat 23
Accellta Enters into Licensing Agreement with Ajinomoto 24
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug 25
EA Pharma Co Ltd – Key Competitors 26
EA Pharma Co Ltd – Key Employees 27
EA Pharma Co Ltd – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Legal and Regulatory 29
Mar 30, 2018: EA Pharma Obtained “Marketing License for Medical Devices” 29
Product News 30
Mar 09, 2018: “LIVACT Granules”-A Branched-chain Amino Acid Formula – Launches in Thailand 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EA Pharma Enters into Collaboration Agreement with Keio University, Tokyo Medical and Dental University, Kitasato University, Nagoya City University, Kagoshima University and KAN Research Institute 11
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 13
EA Pharma Enters into Co-Promotion Agreement with AbbVie 14
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 15
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
Tasly Pharma Enters into Licensing Agreement with EA Pharma 18
EA Pharma to Enter into Licensing Agreement with Cosmo Technologies 19
JW Pharma Enters into Licensing Agreement with EA Pharma 20
EA Pharma Enters into Licensing Agreement with Calypso Biotech 21
LTT Bio-Pharma Enters into License Agreement with Ajinomoto Pharma 22
Ajinomoto Pharma Amends Licensing Agreement with Albireo for Elobixibat 23
Accellta Enters into Licensing Agreement with Ajinomoto 24
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug 25
EA Pharma Co Ltd, Key Competitors 26
EA Pharma Co Ltd, Key Employees 27

List of Figures
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Apache Corporation:企業の戦略・SWOT・財務情報
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Renova Energia SA (RNEW11):企業の財務・戦略的SWOT分析
    Renova Energia SA (RNEW11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sundaram Finance Limited:企業の戦略・SWOT・財務情報
    Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report Summary Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ygm Trading Ltd.:企業の戦略・SWOT・財務分析
    Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mithra Pharmaceuticals SA (MITRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • Northwest Bancshares Inc:企業の戦略・SWOT・財務情報
    Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report Summary Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kurganmashzavod JSC:企業の戦略的SWOT分析
    Kurganmashzavod JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Qantas Airways Limited:企業の戦略・SWOT・財務分析
    Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Anacor Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Anacor Pharmaceuticals Inc (Anacor) is a biopharmaceutical company that discovers, develops and markets small molecule therapeutics based on its boron chemistry platform. The company’s marketed products include a topical solution which is an oxaborole antifungal that is used for the topical …
  • Special Metals Corp:企業の戦略・SWOT・財務分析
    Special Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Special Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Peter’s Food Service Ltd:企業の戦略・SWOT・財務情報
    Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report Summary Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, gl …
  • Africa Oil Corp (AOI):企業の財務・戦略的SWOT分析
    Summary Africa Oil Corp (AOC) is an oil and gas company that discovers, develops, explores and produces oil and gas assets. The company has oil discoveries in Ekales, Agete, Amosing, Ewoi wells in the Lokichar Basin, and others. It owns and operates various blocks including block 9, block 10A, block …
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Lagerwey Wind BV-エネルギー分野:企業M&A・提携分析
    Summary Lagerwey Wind BV (Lagerwey) is an alternative energy company that design and manufacture of wind turbines. The company’s wind turbines include L82-2.0 MW, L93 1.5 MW, L93 2.6 MW, L100 1.5 MW, L100 2.5 MW, L100- NL and L132-3.8 MW. Its technologies comprise turbine modular set-up, Nacelle, ge …
  • Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆